Positron Emission Tomography (PET) Nuclear Medicine Market Size Forecast by 2029

Positron emission tomography (PET) is a nuclear medicine procedure that measures the metabolic activity of body tissue cells. PET is a hybrid of nuclear medicine and biochemical analysis. PET is primarily used in patients with brain or heart conditions, as well as cancer, to visualize biochemical changes in the body, such as the heart muscle's metabolism (the process by which cells convert food into energy after food is digested/absorbed into the blood).

The positron-emission tomography (PET) market is expanding due to a number of factors, including increased demand for PET analysis in radiopharmaceuticals, technological advances in pet imaging, and an increase in the prevalence of various chronic diseases. Positron Emission Tomography (PET) allows for high-resolution and high-sensitivity measurements of the functional processes of biological systems. PET can now be used to study a wide range of functional processes to recent advances in biology and radiochemistry. Furthermore, rising research and market developments are fuelling global market expansion.

Data Bridge Market Research analyses that the positron emission tomography (PET) nuclear medicine market which was USD 9 billion in 2021, is expected to reach USD 27.53 billion by 2029, at a CAGR of 15% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America dominates the positron emission tomography (PET) nuclear medicine market due to the surging levels of investment of the research and development activities.

Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pet-nuclear-medicine-market

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising awareness among the people regarding nuclear medicines and molecular imaging along with increasing geriatric population.

Some of the major players operating in the positron emission tomography (PET) nuclear medicine market are:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact: 

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Sports-Recreation/43777-Positron-Emission-Tomography-PET-Nuclear-Medicine-Market-Size-Forecast-by-2029.html